Stock Events

Stock Events

Clara Technologies 

$0.31
25
+$0+0% Tuesday 18:03

Statistics

Day High
0.7
Day Low
0.7
52W High
11.46
52W Low
0
Volume
1,000
Avg. Volume
769
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

13NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-4.23
-2.75
-1.27
0.21
Expected EPS
-3.02
Actual EPS
-0.17

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-201,039.43Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CLTEF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Vertex Pharmaceuticals is involved in developing treatments for kidney diseases, directly competing with Calliditas' focus on IgA nephropathy.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline has a portfolio of drugs that target various renal conditions, making it a competitor in the nephrology space.
Aurinia Pharmaceuticals
AUPH
Mkt Cap1.73B
Aurinia Pharmaceuticals focuses on the treatment of lupus nephritis, a condition that affects the kidneys, positioning it as a competitor.
Trevena
TRVN
Mkt Cap10,365
Trevena is involved in developing therapies for central nervous system disorders but has expanded into acute and chronic kidney diseases, overlapping with Calliditas' interests.
Akebia Therapeutics
AKBA
Mkt Cap585.97M
Akebia Therapeutics focuses on kidney disease and anemia, directly competing with Calliditas in the nephrology market.
Scholar Rock
SRRK
Mkt Cap2.77B
Scholar Rock is developing a pipeline of drugs targeting fibrotic diseases, including those affecting the kidneys, making it a competitor in the space.

About

Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment of the autoimmune renal disease immunoglobulin A nephropathy. The company's lead product candidate is Setanaxib, a NOX inhibitor that is in Phase 2b/3 clinical trial for the treatment of primary biliary cholangitis; and in Phase 2 clinical trial for the treatment of squamous cell carcinoma of the head and neck cancer and idiopathic pulmonary fibrosis, as well as for type 1 diabetic kidney disease. It also develops Budenofalk 3 mg oral capsules for the treatment of autoimmune hepatitis. The company was incorporated in 2004 and is headquartered in Stockholm, Sweden.
Show more...
CEO
Ms. Renee Aguiar-Lucander
Employees
178
Country
CA
ISIN
CA17989L1022

Listings

OTC Link
US
CLTEF

0 Comments

Share your thoughts

FAQ

What is Clara Technologies stock price today?▼
The current price of CLTEF is $0.31 USD — it has increased by +0% in the past 24 hours. Watch Clara Technologies stock price performance more closely on the chart.
What is Clara Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Clara Technologies stocks are traded under the ticker CLTEF.
What were Clara Technologies earnings last quarter?▼
CLTEF earnings for the last quarter are -0.17 USD per share, whereas the estimation was -3.02 USD resulting in a +94.37% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Clara Technologies revenue for the last year?▼
Clara Technologies revenue for the last year amounts to 0 USD.
What is Clara Technologies net income for the last year?▼
CLTEF net income for the last year is -201,039.43 USD.
How many employees does Clara Technologies have?▼
As of April 03, 2026, the company has 178 employees.
In which sector is Clara Technologies located?▼
Clara Technologies operates in the Health Care sector.
When did Clara Technologies complete a stock split?▼
Clara Technologies has not had any recent stock splits.
Where is Clara Technologies headquartered?▼
Clara Technologies is headquartered in Stockholm, CA.